
Avient Corp (AVNT) Stock Forecast & Price Target
Avient Corp (AVNT) Analyst Ratings
Bulls say
Avient Corp reports a positive financial outlook, underscored by a 5% increase in organic sales, driven significantly by robust growth in the healthcare sector, which experienced a 14% year-over-year increase in the first half of 2025. Additionally, four of the nine end markets, representing 40% of the company's sales, are currently showing growth, contributing to an overall organic sales rise of approximately 2% expected for 2025. Despite anticipated challenges in the consumer end market in the latter half of 2025, the diversified product portfolio and strong performance in key sectors suggest a resilient business model.
Bears say
Avient Corp has experienced a decline in organic sales, with a notable 2% drop in the first quarter of 2024, despite some recovery indications in subsequent quarters. The outlook for demand in the chemicals sector has been negative, with signs of weakening volume anticipated in the second half of 2025, raising concerns about future revenue stability. Additionally, while a declining dollar could provide a temporary boost, the underlying demand challenges in key segments may overshadow any potential benefits from currency fluctuations.
This aggregate rating is based on analysts' research of Avient Corp and is not a guaranteed prediction by Public.com or investment advice.
Avient Corp (AVNT) Analyst Forecast & Price Prediction
Start investing in Avient Corp (AVNT)
Order type
Buy in
Order amount
Est. shares
0 shares